Avadel Pharmaceuticals (AVDL)
(Delayed Data from NSDQ)
$17.81 USD
-0.01 (-0.06%)
Updated Apr 26, 2024 04:00 PM ET
After-Market: $17.82 +0.01 (0.06%) 7:58 PM ET
2-Buy of 5 2
F Value D Growth C Momentum F VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 5/2/24 |
---|---|
Current Quarter | -0.25 |
EPS Last Quarter | -0.32 |
Last EPS Surprise | -14.29% |
ABR | 1.10 |
Earnings ESP
|
7.26% |
---|---|
Current Year | -0.46 |
Next Year | 0.85 |
EPS (TTM) | -1.91 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 25.09M | 36.07M | 161.76M | 294.47M |
# of Estimates | 5 | 5 | 5 | 4 |
High Estimate | 27.10M | 39.10M | 176.80M | 334.20M |
Low Estimate | 23.01M | 33.50M | 146.50M | 248.00M |
Year ago Sales | 0.00M | 1.50M | 27.96M | 161.76M |
Year over Year Growth Est. | NA | 2,304.67% | 478.49% | 82.03% |
Earnings Estimates
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.25 | -0.13 | -0.46 | 0.85 |
# of Estimates | 5 | 5 | 7 | 4 |
Most Recent Consensus | -0.31 | -0.15 | -0.39 | 0.77 |
High Estimate | -0.18 | -0.06 | -0.05 | 1.50 |
Low Estimate | -0.31 | -0.17 | -1.02 | 0.34 |
Year ago EPS | -0.48 | -0.70 | -2.00 | -0.46 |
Year over Year Growth Est. | 47.92% | 81.43% | 77.00% | 285.64% |
Agreement - Estimate Revisions
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 0 | 0 | 1 | 1 |
Up Last 30 Days | 0 | 0 | 1 | 1 |
Up Last 60 Days | 1 | 2 | 5 | 4 |
Down Last 7 Days | 1 | 0 | 0 | 0 |
Down Last 30 Days | 1 | 0 | 0 | 0 |
Down Last 60 Days | 3 | 1 | 1 | 0 |
Magnitude - Consensus Estimate Trend
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.25 | -0.13 | -0.46 | 0.85 |
7 Days Ago | -0.24 | -0.13 | -0.46 | 0.83 |
30 Days Ago | -0.24 | -0.13 | -0.46 | 0.83 |
60 Days Ago | -0.25 | -0.15 | -0.44 | 0.68 |
90 Days Ago | -0.25 | -0.15 | -0.42 | 0.66 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (3/2024) |
Next Qtr (6/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.23 | -0.13 | -0.43 | 0.34 |
Zacks Consensus Estimate | -0.25 | -0.13 | -0.46 | 0.85 |
Earnings ESP | 7.26% | 0.00% | 6.81% | -60.12% |
Surprise - Reported Earnings History
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Quarter Ending (6/2023) |
Quarter Ending (3/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.32 | -0.41 | -0.70 | -0.48 | NA |
Estimate | -0.28 | -0.35 | -0.39 | -0.37 | NA |
Difference | -0.04 | -0.06 | -0.31 | -0.11 | -0.13 |
Surprise | -14.29% | -17.14% | -79.49% | -29.73% | -35.16% |
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more